Cytogenetic analysis delineates a spectrum of chromosomal changes that can distinguish non-MALT marginal zone B-cell lymphomas among mature B-cell entities: A description of 103 cases

Leukemia

Volumn 19, Issue 10, 2005, Pages 1818-1823

  Callet Bauchu, Evelyne ^a,b   Baseggio, L ^a,b   Felman, P ^a,b   Traverse Glehen, A ^a,b   Berger, F ^a,b   Morel, D ^a   Gazzo, S ^a,b   Poncet, C ^a   Thieblemont, C ^a,b   Coiffier, B ^a   Magaud, J P ^a,b   Salles, G ^a,b  

^a CENTRE HOSPITALIER LYON SUD   (France)

^b UNIVERSITÉ LYON 1   (France)

Author keywords

Chromosomal abnormalities; Marginal zone lymphoma; t(3; 7)(q13; q31)

Indexed keywords

ADULT; AGED; ARTICLE; B CELL LYMPHOMA; B LYMPHOCYTE; CANCER SURVIVAL; CHROMOSOME 12Q; CHROMOSOME 18Q; CHROMOSOME 3Q; CHROMOSOME 6Q; CHROMOSOME 7Q; CHROMOSOME 8P; CHROMOSOME ABERRATION; CHROMOSOME DELETION; CHRONIC LYMPHATIC LEUKEMIA; CYTOGENETICS; FEMALE; FOLLICULAR LYMPHOMA; HUMAN; HUMAN TISSUE; KARYOTYPE; LYMPHOCYTOMA; MAJOR CLINICAL STUDY; MALE; MANTLE CELL LYMPHOMA; MARGINAL ZONE LYMPHOMA; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; PRIORITY JOURNAL; PROGNOSIS; TRISOMY;

EID: 27144432879     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/sj.leu.2403909     Document Type: Article

References (20)

1. Jaffe E, Harris NL, Stein H, Vardiman JW. World Health Organization Classification of Tumors. Pathology and Genetics of Tumors of Haematopoietic and Lymphoid Tissues, International Agency for Research on Cancer. Lyon: IARC Press, 2001.
2. Dierlamm J, Pittaluga S, Wlodarska I, Stul M, Thomas J, Boogaerts M et al. Marginal zone B-cell lymphomas of different sites share similar cytogenetic and morphologic features. Blood 1996; 87 299-307.
3. Ott M, Rosenwald A, Katzenberger T, Dreyling M, Krumdieck AK, Kalla J et al. Marginal zone B-cell lymphomas (MZBL) arising at different sites represent different biological entities. Genes Chromosomes Cancer 2000; 28: 380-386.
4. Solé F, Salido M, Espinet B, Garcia JL, Martinez-Climent JA, Granada I et al. Splenic marginal zone B-cell lymphomas: Two cytogenetic subtypes, one with gains of 3q and the other with loss of 7q. Haematologica 2001; 86: 71-77.
5. Dierlamm J. Genetic abnormalities in marginal zone B-cell lymphoma. Haematologica 2003; 88: 8-12.
6. Callet-Bauchu E, Salles G, Gazzo S, Poncet C, Morel D, Pages J et al. Translocations involving the short arm of chromosome 17 in chronic B-lymphoid disorders: Frequent occurrence of dicentric rearrangements and possible association with adverse outcome. Leukemia 1999; 13: 460-468.
7. Mitelman F (ed). An International System for Human Cytogenetic Nomenclature (ISCN). Basel: S Karger, 1995.
8. Gazzo S, Baseggio L, Coignet L, Poncet C, Morel D, Coiffier B et al. Cytogenetic and molecular delineation of a region of chromosome 3q commonly gained in marginal zone B-cell lymphoma. Haematologica 2003; 88: 31-38.
9. Thieblemont C, Nasser V, Felman P, Leroy K, Gazzo S, Callet-Bauchu E et al. Small lymphocytic lymphoma (SLL), marginal zone B-cell lymphoma (MZL), mantle cell lymphoma (MCL) exhibit distinct gene-expression profiles allowing molecular diagnosis. Blood 2004; 103: 2727-2737.
10. Monni O, Oinonen R, Elonen E, Franssila K, Teerenhovi L, Joensuu H et al. Gain of 3q and deletion of 11q22 are frequent aberrations in mantle cell lymphoma. Genes Chromosomes Cancer 1998; 21: 298-307.
11. Gahrton G, Robert KH, Friberg K, Zech L, Bird AG. Extra chromosome 12 in chronic lymphocytic leukaemia. Lancet 1980; 1: 146-147.
12. Horsman DE, Connors JM, Pantzar T, Gascoyne RD. Analysis of secondary chromosomal alterations in 165 cases of follicular lymphoma with t(14;18). Genes Chromosomes Cancer 2001; 30: 375-382.
13. Offit K, Louie DC, Parsa NZ, Noy A, Chaganti RSK. Del(7)(q32) is associated with a subset of small lymphocytic lymphoma with plasmacytoid features. Blood 1995; 86: 2365-2370.
14. Troussard X, Mauvieux L, Radford-Weiss I, Rack K, Valensi F, Garand R et al. Genetic analysis of splenic lymphoma with villous lymphocytes. Br J Haematol 1998; 101: 712-721.
15. Rosenwald A, Wright G, Wiestner A, Chan WC, Connors JM, Campo E et al. The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma. Cancer Cell 2003; 3: 185-197.
16. Hernandez JM, Garcia JL, Guttierrez NC, Mollejo M, Martinez-Climent JA, Flores T et al. Novel genomic imbalances in B-cell splenic marginal zone lymphomas revealed by comparative genomic hybridization and cytogenetics. The Am J Pathol 2001; 158: 1843-1850.
17. Boonstra R, Bosga-Bouwer A, Van Imhoff GW, Krause V, Palmer M, Coupland RW et al. Splenic marginal zone lymphomas presenting with splenomegaly and typical immunophenotype are characterized by allelic loss in 7q31-32. Mod Pathol 2003; 16: 1210-1217.
18. Mateo M, Mollejo M, Villuendas R, Algara P, Sanchez-Beato M, Martinez P et al. 7q31-32 allelic loss is a frequent finding in splenic marginal zone lymphoma. Am J Pathol 1999; 154: 1583-1589.
19. Berger F, Felman P, Thieblemont C, Pradier T, Baseggio L, Bryon PA et al. Non-MALT marginal zone B-cell lymphomas: A description of clinical presentation and outcome in 124 patients. Blood 2000; 95: 1950-1956.
20. Algara P, Mateo MS, Sanchez-Beato M, Mollejo M, Navas IC, Romero L et al. Analysis of the IgV(H) somatic mutations in splenic marginal zone lymphoma defines a group of unmutated cases with frequent 7q deletion and adverse clinical course. Blood 2002; 99: 1299-1304.